Effects of SGLT2 inhibitors in diabetic patients receiving doxorubicin-based chemotherapy for breast cancer

被引：0
|
作者：
Abdelnabi, M. [1 ]
Hassanein, Z. [2 ]
Benjanuwattra, J. [1 ]
Saleh, Y. [3 ]
Almaghraby, A. [4 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Alexandria Univ, Fac Med, Clin Oncol & Nucl Med Dept, Alexandria, Egypt
[3] Houston Methodist DeBakey Cardiol Associates, Houston, TX USA
[4] Alexandria Univ, Fac Med, Cardiol Dept, Alexandria, Egypt
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] FAERS reports of diabetic ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2017, 1653 (1) : 7 - 7
  • [42] SGLT2 inhibitors increase the risk of diabetic ketoacidosis
    Reactions Weekly, 2016, 1603 (1) : 9 - 9
  • [43] SGLT2 inhibitors may cause diabetic ketoacidosis
    Reactions Weekly, 2015, 1553 (1) : 4 - 4
  • [44] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 4 - 5
  • [45] Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung C.
    Wexler, Deborah J.
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [46] SGLT2 inhibitors increase risk of diabetic ketoacidosis
    Reactions Weekly, 2017, 1656 (1) : 12 - 12
  • [47] SGLT2 inhibitors and diabetic ketoacidosis — a growing concern
    Guillermo E. Umpierrez
    Nature Reviews Endocrinology, 2017, 13 : 441 - 442
  • [48] SGLT2 inhibitors: diabetic ketoacidosis in the surgical setting
    Reactions Weekly, 2020, 1789 (1) : 10 - 10
  • [49] SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
    Kawanami, Daiji
    Matoba, Keiichiro
    Takeda, Yusuke
    Nagai, Yosuke
    Akamine, Tomoyo
    Yokota, Tamotsu
    Sango, Kazunori
    Utsunomiya, Kazunori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [50] Strengthened diabetic ketoacidosis warning for SGLT2 inhibitors
    Reactions Weekly, 2018, 1713 (1) : 3 - 3
12345